Diagnosticos da America S.A.
MarketLine (a Datamonitor Company)
26 Nov 2013
Available for Immediate Download
Diagnosticos da America S.A. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Diagnosticos da America S.A. required for business and competitor intelligence needs - Intelligence on Diagnosticos da America S.A.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Diagnosticos da America S.A., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Diagnosticos da America (DASA) is a medical diagnostics company engaged in providing clinical analysis, imaging services and vaccination services. The company also provides support services for more than 3,000 laboratories in Brazil. The company primarily operates in Brazil, where it is headquartered in Barueri and employs around 17,911 people. The company recorded revenues of BRL2,179.9 million (approximately $1,309.4 million) in the fiscal year ended December 2011, an increase of 45.1% over 2010. The company's operating profit was BRL374.6 million (approximately $225 million) in fiscal 2011, an increase of 27.6% over 2010. Its net profit was BRL145.5 million (approximately $87.4 million) in fiscal 2011, an increase of 48.5% over 2010. Reasons to Purchase: - Gain understanding of Diagnosticos da America S.A. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Diagnosticos da America S.A. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Diagnosticos da America S.A. your competitors' business structure, strategy and prospects